Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TNET | TRINET GROUP INC | $5.25B | $103.92 | $133.67 | 28.62% | Strong Buy | 3 | -47.95% | -17.41% | N/A | N/A | ||||
| NGNE | NEUROGENE INC | $432.37M | $33.31 | $42.67 | 28.09% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| EYPT | EYEPOINT PHARMACEUTICALS INC | $616.68M | $11.84 | $33.40 | 182.09% | Strong Buy | 5 | N/A | N/A | N/A | N/A | ||||
| CPA | COPA HOLDINGS SA | $4.60B | $109.36 | $164.33 | 50.27% | Strong Buy | 3 | 6.53% | -13.24% | N/A | N/A | ||||
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | $1.41B | $16.17 | $38.60 | 138.71% | Strong Buy | 5 | N/A | N/A | N/A | N/A | ||||
| GEF | GREIF INC | $3.01B | $63.90 | $80.00 | 25.20% | Strong Buy | 3 | 5.36% | N/A | N/A | N/A | ||||
| APTO | APTOSE BIOSCIENCES INC | $19.25M | $1.18 | $11.33 | 860.42% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| ANNX | ANNEXON INC | $400.15M | $4.33 | $15.80 | 264.90% | Strong Buy | 5 | N/A | N/A | N/A | N/A | ||||
| ACLS | AXCELIS TECHNOLOGIES INC | $3.68B | $113.23 | $151.67 | 33.95% | Strong Buy | 3 | -6.01% | N/A | N/A | N/A | ||||
| DNTH | DIANTHUS THERAPEUTICS INC | $752.23M | $25.63 | $42.40 | 65.43% | Strong Buy | 5 | 6.22% | N/A | N/A | N/A | ||||
| APGE | APOGEE THERAPEUTICS INC | $2.94B | $50.31 | $72.25 | 43.61% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| SNDX | SYNDAX PHARMACEUTICALS INC | $1.72B | $20.29 | $35.50 | 74.96% | Strong Buy | 6 | N/A | N/A | N/A | N/A | ||||
| RRX | REGAL REXNORD CORP | $10.62B | $159.68 | $195.60 | 22.49% | Strong Buy | 5 | -5.60% | N/A | N/A | N/A | ||||
| IMVT | IMMUNOVANT INC | $4.46B | $30.70 | $51.33 | 67.21% | Strong Buy | 9 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.